alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid has been researched along with gyki 47261 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abrahám, G; Andrási, F; Berzsenyi, P; Csuzdi, E; Hámori, T; Hársing, LG; Horváth, G; Horváth, K; Kapus, G; Király, I; Ling, I; Pallagi, I; Patthy, M; Sólyom, S; Tarnawa, I | 1 |
| Hazai, E; Ingelman-Sundberg, M; Monostory, K; Porsmyr-Palmertz, M; Tamási, V; Vereczkey, L | 1 |
2 other study(ies) available for alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and gyki 47261
| Article | Year |
|---|---|
New non competitive AMPA antagonists.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Anti-Anxiety Agents; Anticonvulsants; Benzodiazepines; Disease Models, Animal; Drug Design; Humans; Kainic Acid; Male; Mice; Molecular Structure; Muscarinic Agonists; Oxotremorine; Patch-Clamp Techniques; Purkinje Cells; Rats; Receptors, AMPA; Retina; Seizures; Structure-Activity Relationship | 2000 |
GYKI-47261, a new AMPA [2-amino-3-(3-hydroxymethylisoxazole-4-yl)propionic acid] antagonist, is a CYP2E1 inducer.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Benzodiazepines; Cytochrome P-450 CYP2E1; Dose-Response Relationship, Drug; Enzyme Induction; Excitatory Amino Acid Antagonists; Gene Expression Regulation, Enzymologic; Hepatocytes; Humans; Male; Rats; Rats, Wistar | 2003 |